Richard Adam Norwitt, serving as the President and CEO of Amphenol Corp (NASDAQ:APH), has finalized a series of equity transactions resulting in the sale of approximately $18.7 million worth of company shares. The transactions were executed over a five-day period beginning May 1 and concluding on May 5, 2026.
Transaction Details and Execution
The total volume of Class A Common Stock sold by Norwitt amounted to 130,775 shares. The pricing for these transactions fluctuated throughout the week, with individual share prices ranging from $142.0416 to $143.8951. The breakdown of the sales is as follows:
- May 1: Norwitt sold 61,072 shares at a weighted average price of $143.8951. During this session, individual trades were recorded between $143.50 and $146.30 per share.
- May 4: A total of 52,203 shares were sold at a weighted average price of $142.0416, with trade prices falling between $142.00 and $142.1351.
- May 5: The final tranche involved the sale of 17,500 shares at a weighted average price of $143.2061, with specific trades occurring in the range of $143.1550 to $143.2514.
These sales were preceded by the acquisition of an equivalent number of shares through the exercise of stock options. Norwitt exercised options to acquire 130,775 shares of Class A Common Stock at a price of $22.3725 per share, representing a total cost of approximately $2,925,763. These specific options are set to expire on May 23, 2029.
Following these movements, Norwitt's direct holdings in Class A Common Stock stand at 1,927,507 shares. He also maintains indirect ownership of 864,177 shares via the Norwitt Family Trust and 3,968 shares through an IRA. Furthermore, he retains stock options for an additional 899,788 shares, which carry an exercise price of $22.3725.
Financial Performance and Market Position
The insider activity occurs while Amphenol continues to demonstrate robust operational metrics. For the first quarter of 2026, the company reported adjusted earnings per share (EPS) of $1.06, which surpassed the anticipated $0.94. Revenue for the period reached $7.62 billion, exceeding the forecasted $7.08 billion. Notably, the company saw orders rise to a record $9.4 billion, marking a 77.6% increase compared to the previous year.
Looking ahead to the second quarter, Amphenol has provided guidance estimating sales of approximately $8.15 billion and an EPS of $1.15, which sits $0.10 above consensus estimates. In light of these results, Barclays raised its price target for the stock to $180, noting strong growth in IT Datacom sales, while Evercore ISI maintained an Outperform rating with a similar $180 price target.
Key Market Insights
- Strong Operational Momentum: The company's record $9.4 billion in orders and significant year-over-year growth indicate high demand within its core sectors, potentially impacting the broader communications and technology infrastructure markets.
- Positive Analyst Sentiment: Recent upward revisions to price targets by major institutions like Barclays reflect confidence in the company's IT Datacom segment.
Risks and Uncertainties
- Valuation Concerns: Despite a 71.7% return over the past year, analysis suggests that Amphenol may currently be overvalued relative to its Fair Value, placing it on a list of most overvalued stocks.
- Capital Structure Shifts: The company's announcement regarding the pricing of a two-tranche senior notes offering totaling €1.1 billion, expected to close in May 2026, introduces new elements to its debt profile and balance sheet management.